Home > Financial Ratios > HIKAL

HIKAL
Core EBITDA Margin

    Back to All Ratios
HIKAL is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for HIKAL
Please provide your vote to see the results

HIKAL Last 5 Year Core EBITDA Margin History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Core EBITDA Margin(%) 14.9612.7117.5318.7718.12

What is the latest Core EBITDA Margin ratio of HIKAL ?

The latest Core EBITDA Margin ratio of HIKAL is 14.96 based on Mar2024 Consolidated results.
Year Core EBITDA Margin
Mar202414.96
Mar202312.71
Mar202217.53
Mar202118.77
Mar202018.12

How is Core EBITDA Margin of HIKAL Trending?

Years Core EBITDA Margin % Change
Mar2024 14.96
17.70
Mar2023 12.71
-27.50
Mar2022 17.53
-6.61
Mar2021 18.77
3.59
Mar2020 18.12 -

Other Financial Ratios of HIKAL


Compare Core EBITDA Margin ratio of peers of HIKAL

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
HIKAL ₹4,285.9 Cr -0.4% -13.8% 21.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹418,744.0 Cr -4.2% -7.7% 24.1% Stock Analytics
DIVIS LABORATORIES ₹152,209.0 Cr -0.6% -5.6% 57.5% Stock Analytics
CIPLA ₹117,762.0 Cr 3.3% -4.8% 6.5% Stock Analytics
DR REDDYS LABORATORIES ₹99,705.3 Cr -2.4% -12.8% 1.1% Stock Analytics
ZYDUS LIFESCIENCES ₹95,929.3 Cr -0.3% -2.1% 24.5% Stock Analytics


HIKAL Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
HIKAL

-0.4%

-13.8%

21.5%

SENSEX

0.3%

-1.8%

8.6%


You may also like the below Video Courses